Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,375 | 1,612 | 99.2% |
| Education | $168.52 | 14 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,742 | 233 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,232 | 118 | $0 (2024) |
| PFIZER INC. | $2,004 | 183 | $0 (2024) |
| Novo Nordisk Inc | $1,957 | 173 | $0 (2024) |
| Lilly USA, LLC | $1,540 | 113 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $968.30 | 70 | $0 (2024) |
| Amarin Pharma Inc. | $814.98 | 63 | $0 (2022) |
| GlaxoSmithKline, LLC. | $756.09 | 45 | $0 (2024) |
| Amgen Inc. | $722.37 | 45 | $0 (2024) |
| Merck Sharp & Dohme LLC | $538.05 | 42 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,819 | 197 | ABBVIE INC. ($762.15) |
| 2023 | $3,137 | 215 | ABBVIE INC. ($649.05) |
| 2022 | $3,250 | 233 | ABBVIE INC. ($665.91) |
| 2021 | $3,059 | 261 | AbbVie Inc. ($448.07) |
| 2020 | $2,507 | 185 | AstraZeneca Pharmaceuticals LP ($291.10) |
| 2019 | $2,239 | 174 | Novo Nordisk Inc ($301.92) |
| 2018 | $2,125 | 180 | AstraZeneca Pharmaceuticals LP ($326.85) |
| 2017 | $2,407 | 181 | AstraZeneca Pharmaceuticals LP ($454.59) |
All Payment Transactions
1,626 individual payment records from CMS Open Payments — Page 1 of 66
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $9.46 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: UROLOGY | ||||||
| 12/17/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: Neuroscience | ||||||
| 12/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $5.26 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Oncology | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: PAIN | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.44 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $1.13 | General |
| Category: PAIN | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $1.96 | General |
| Category: PAIN | ||||||
| 11/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.69 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: PAIN | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.87 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 3,712 | 4,293 | $346,824 | $229,743 |
| 2022 | 30 | 3,235 | 3,717 | $269,355 | $169,729 |
| 2021 | 30 | 2,687 | 3,093 | $236,746 | $150,190 |
| 2020 | 26 | 2,552 | 2,973 | $243,297 | $127,133 |
All Medicare Procedures & Services
112 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 303 | 658 | $86,856 | $57,862 | 66.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 149 | 149 | $44,700 | $41,819 | 93.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 280 | 280 | $43,680 | $34,253 | 78.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 272 | 272 | $27,200 | $19,159 | 70.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 161 | 161 | $12,880 | $11,513 | 89.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 116 | 162 | $15,228 | $9,360 | 61.5% |
| 92552 | Test for hearing various pitches using earphone | Office | 2023 | 272 | 273 | $9,828 | $6,502 | 66.2% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 311 | 311 | $9,330 | $5,391 | 57.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 296 | 296 | $8,880 | $5,130 | 57.8% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 120 | 121 | $18,634 | $5,010 | 26.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 164 | 164 | $5,740 | $4,665 | 81.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 81 | 106 | $7,950 | $4,624 | 58.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 30 | 30 | $6,450 | $4,426 | 68.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 144 | 144 | $5,040 | $4,093 | 81.2% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 150 | 150 | $5,250 | $3,690 | 70.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 20 | $3,600 | $2,716 | 75.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 74 | 74 | $3,922 | $2,665 | 68.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 239 | 253 | $17,204 | $2,314 | 13.4% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 243 | 243 | $2,430 | $1,039 | 42.8% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 41 | 41 | $1,845 | $995.89 | 54.0% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 27 | 29 | $2,088 | $761.07 | 36.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 72 | $2,376 | $715.56 | 30.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 135 | 212 | $3,604 | $673.47 | 18.7% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 13 | 13 | $715.00 | $268.06 | 37.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 33 | 42 | $714.00 | $92.40 | 12.9% |
About Dr. Constance Irick, M.D
Dr. Constance Irick, M.D is a Family Medicine healthcare provider based in Olathe, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1346235272.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Constance Irick, M.D has received a total of $21,543 in payments from pharmaceutical and medical device companies, with $2,819 received in 2024. These payments were reported across 1,626 transactions from 80 companies. The most common payment nature is "Food and Beverage" ($21,375).
As a Medicare-enrolled provider, Irick has provided services to 12,186 Medicare beneficiaries, totaling 14,076 services with total Medicare billing of $676,795. Data is available for 4 years (2020–2023), covering 112 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Olathe, KS
- Active Since 09/16/2005
- Last Updated 02/12/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346235272
Products in Payments
- NURTEC ODT (Drug) $1,397
- FARXIGA (Drug) $1,188
- UBRELVY (Drug) $1,101
- JARDIANCE (Drug) $927.05
- Ozempic (Drug) $905.60
- VRAYLAR (Drug) $901.64
- Vascepa (Drug) $814.98
- TRULICITY (Drug) $542.49
- TRELEGY ELLIPTA (Drug) $452.03
- CHANTIX (Drug) $443.38
- Aimovig (Biological) $438.56
- MOUNJARO (Drug) $430.87
- QULIPTA (Drug) $426.26
- XIFAXAN (Drug) $409.64
- Rybelsus (Drug) $368.12
- EMGALITY (Drug) $313.45
- Kerendia (Drug) $309.89
- TROKENDI XR (Drug) $309.35
- ELIQUIS (Drug) $288.58
- VYVANSE (Drug) $287.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Olathe
Travis Keller, Md, MD
Family Medicine — Payments: $13,363
Dr. Fred Church, D.o, D.O
Family Medicine — Payments: $13,106
Dr. Holly Kaufman, M.d, M.D
Family Medicine — Payments: $12,247
Dr. Anthony Justesen, Md, MD
Family Medicine — Payments: $5,767
Dr. Young Cho, M.d, M.D
Family Medicine — Payments: $5,229
Kathryn Chartrand, Do, DO
Family Medicine — Payments: $4,596